Elevance raises 2026 profit outlook on tighter control of medical costs
Health insurer Elevance Health lifted its full-year adjusted profit forecast to at least $29 per share from at least $27, according to Reuters.
- published on Newsmetry
- original source published
the public page opens no earlier than 15 minutes after we detect the story. approved stories may reach the api sooner. connect the api →
what happened
Health insurer Elevance Health on Wednesday raised its full-year adjusted profit outlook. It now expects at least $29 per share, up from its previous guidance of at least $27. Data compiled by LSEG show analysts polled on average expect $27.23 per share.
In the third quarter the company posted a medical loss ratio of 90.6%, meaning the share of premiums spent on medical care. Analysts had expected 91.17%. Reuters reported that Elevance credits disciplined management of medical spending for the improvement.
In recent years insurers have faced rising demand for behavioral health services and specialty drugs in government-backed plans, which has pushed their costs higher.
why it matters
For markets, the key point is that the medical loss ratio came in below expectations, which suggests cost control is better than analysts had assumed. Investors watching the managed care segment will track whether this trend in medical spending holds across peers.
market impact
Elevance and US health insurers: higher guidance and lower costs support the sector
tags
instruments
sources
- Elevance lifts 2026 profit forecast on better medical cost management — Reuters, 21 October 2026 at 10:02 UTC
- Elevance lifts 2026 profit forecast on better medical cost management — Reuters, 21 October 2026 at 10:10 UTC
prepared by the newsmetry newsroom with ai assistance from the sources listed below. not investment advice.
the public page opens no earlier than 15 minutes after we detect the story. approved stories may reach the api sooner.
get stories in real time ↗